Feedback stock | Expectations for 2026, valuation & analysis

Feedback

AIM:FDBK

£ 0,13

£0,00 (0,00%)

0,13 £

£0,00 (0,00%)

End-of-day quote: 04/10/2026

Feedback Stock Value

The current analyst rating for Feedback is Buy.

Buy

Feedback Company Info

EPS Growth 5Y

13,99%

Market Cap

£0,01 B

Long-Term Debt

£0,00 B

Quarterly earnings

05/23/2026 (E)

Dividend

£0,00

Dividend Yield

0,00%

Founded

1958

Industry

Health Care

Country

United Kingdom

Website

Feedback

ISIN Number

GB00BJN59X09

Website

http://fbkmed.com/feedback-plc

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

£0,60

361.54%

Last Update: 04/11/2026

Analysts: 1

Highest Price Target £0,60

Average Price Target £0,60

Lowest Price Target £0,60

In the last five quarters, Feedback’s Price Target has fallen from £2,40 to £0,60 - a -75,00% decrease. One analysts predict that Feedback’s share price will increase in the coming year, reaching £0,60. This would represent an increase of 361,54%.

Top growth stocks in the health care sector (5Y.)

What does Feedback do?

Feedback plc engages in developing digital solutions for the healthcare sector, focusing on communication and operation among medical practitioners and institutions. The company revolve around patient outcomes by integrating technology into clinical workflows, facilitating remote consultations, and operational processes across healthcare systems. Business Segments The company operates through several business segments. These segments encapsulate the development and deployment of software solut...

Business Segments

The company operates through several business segments. These segments encapsulate the development and deployment of software solutions tailored to specific clinical needs and operational exigencies.

Business Strategy

The company implements a dynamic business strategy centered on innovation, user engagement, and continuous improvement in healthcare delivery. The company strives to accelerate its sales processes through well-structured phases, focusing on specific customer use cases. The company harnesses its understanding of healthcare environments to pinpoint use cases that promise significant revenue potential.

The company aims to leapfrog conventional sales cycles by utilizing proven frameworks, thus positioning itself favorably in markets with rapid adoption capabilities. Furthermore, the company aims to amplify its sales reach by promoting successful use cases.

Products and Services

The company offers a suite of products designed for the digital healthcare landscape. The core products include CareLocker and Bleepa, which serve distinct yet complementary functions within healthcare operations.

CareLocker is a digital patient record system that allows healthcare professionals to manage and share patient information securely and efficiently. This platform is engineered to enhance patient engagement and streamline administrative tasks, significantly benefiting both providers and patients. It supports the digitization of clinical records, thus fostering efficient accessibility and collaboration among healthcare teams.

Bleepa serves as a communication tool designed to improve the flow of information between healthcare professionals. This platform replaces traditional communication methods, such as pagers and other less efficient messaging systems, thereby offering real-time, auditable exchanges of clinical information.

Geographical Markets Served

The company primarily serves markets in the United Kingdom and India, with aspirations to expand into North America and the European Union.

Customers

The company serves an array of customers, including healthcare institutions, clinicians, and ancillary service providers. The company's clientele spans hospitals, healthcare trusts, and private care facilities across its primary markets in the UK and India. The category of healthcare clientele includes NHS trusts, private hospitals, veterinary sectors, and individual medical practitioners.

Trade Names

The company currently holds various trade names associated with its product offerings, prominently including Bleepa and CareLocker.

Sales and Marketing

The company employs a multifaceted approach to sales and marketing, emphasizing direct engagement with healthcare providers through targeted outreach and innovative marketing strategies. The marketing strategies encompass a combination of digital channels, industry partnerships, and direct sales initiatives, aimed at capturing the attention of potential customers while bolstering the company's reputation within the healthcare sector.

The company utilizes a hybrid model of sales that includes both internal sales teams and external lead generation services to optimize sales efforts. The company maintains close partnerships with stakeholders throughout the healthcare supply chain, thus providing comprehensive support and service throughout the implementation of its solutions.

History

Feedback plc was founded in 1958. The company was incorporated in 1958.

New support ticket

Explore

Feedback Stock Value

Feedback Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Feedback do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Feedback Stock Value

Feedback Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Feedback do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.